The effect of diagnostic criteria on outcome measures in preclinical and prodromal Alzheimer's disease: Implications for trial design

INTRODUCTION: We investigated the influence of different inclusion criteria for preclinical and prodromal Alzheimer's disease (AD) on changes in biomarkers and cognitive markers and on trial sample size estimates. METHODS: We selected 522 cognitively normal subjects and 872 subjects with mild c...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertens, Daniela, Tijms, Betty M., Vermunt, Lisa, Prins, Niels D., Scheltens, Philip, Visser, Pieter Jelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671625/
https://www.ncbi.nlm.nih.gov/pubmed/29124109
http://dx.doi.org/10.1016/j.trci.2017.08.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671625/
https://www.ncbi.nlm.nih.gov/pubmed/29124109
http://dx.doi.org/10.1016/j.trci.2017.08.005

Ejemplares similares